NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 3 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85 | -100.0% | 5,378 | +74.0% | 0.00% | -100.0% |
Q4 2020 | $536,000 | +350.4% | 3,091 | +190.2% | 0.00% | – |
Q3 2020 | $119,000 | -5.6% | 1,065 | -50.0% | 0.00% | -100.0% |
Q2 2020 | $126,000 | -8.0% | 2,132 | +5.4% | 0.00% | 0.0% |
Q1 2020 | $137,000 | +30.5% | 2,023 | +62.1% | 0.00% | – |
Q4 2019 | $105,000 | – | 1,248 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |